Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center

M Bosaeed, A Ahmad, A Alali [...]

Infectious Diseases: Research and Treatment

Retricted access

Case report

First published 2020-4

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane

Eduard Argudo, Jordi Riera, Sonia Luque [...]

Perfusion

Retricted access

Review article

First published 2015-9

Ceftolozane/Tazobactam

Allana J. Sucher, Elias B. Chahine, Peter Cogan [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2021

The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis

Li-Ting Wang, Wei-Ting Lin, Chih-Cheng Lai [...]

Therapeutic Advances in Drug Safety

Open access

Case report

First published 2019

Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series

Xing Tan, Ryan P. Moenster

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2023

Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing Escherichia coli and Klebsiella pneumoniae : a systematic review and meta-analysis

Marzieh Rahim Khorasani, Soodabeh Rostami, Arash Bakhshi [...]

Therapeutic Advances in Infectious Disease

Retricted access

Research article

First published 2020-9

Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions

Harmanjeet Harmanjeet, Het Jani, Syed Tabish R Zaidi [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Retricted access

Research article

First published 2018-06

Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013–2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility

Dee Shortridge, Michael A. Pfaller, Mariana Castanheira [...]

Microbial Drug Resistance

Retricted access

Research article

First published 2017-3

Compatibility of Ceftazidime-Avibactam,Ceftolozane-Tazobactam,and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water

Kevin Meyer, Maressa Santarossa, Larry H. Danziger [...]

Hospital Pharmacy

Open access

Research article

First published 2020-1

Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia

Jesus Ruiz, Alejandra Ferrada, Miguel Salavert [...]

Dose-Response

Search results